Nobilis IB Primo QX (--) lyophilisate for oculonasal suspension
Nobilis IB Primo QX (--) lyophilisate for oculonasal suspension
Authorised
- Avian infectious bronchitis virus, type QX, strain D388, Live
Product identification
Medicine name:
Nobilis IB Primo QX (--) lyophilisate for oculonasal suspension
Active substance:
- Avian infectious bronchitis virus, type QX, strain D388, Live
Target species:
-
Chicken
Route of administration:
-
Coarse spray
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type QX, strain D388, LivePresentation_strength:10⁴·° – 10⁵·⁵ EID₅₀ Reference:2.C.2.1 Index:0
Pharmaceutical form:
-
Lyophilisate for oculonasal suspension
Withdrawal period by route of administration:
-
Coarse spray
- Chicken
-
Not applicable0dayZero days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Austria
-
Belgium
-
Bulgaria
-
Croatia
-
Cyprus
-
Czechia
-
Denmark
-
Estonia
-
Finland
-
France
-
Germany
-
Greece
-
Hungary
-
Iceland
-
Ireland
-
Italy
-
Latvia
-
Liechtenstein
-
Lithuania
-
Luxembourg
-
Malta
-
Netherlands
-
Norway
-
Poland
-
Portugal
-
Romania
-
Slovakia
-
Slovenia
-
Spain
-
Sweden
-
United Kingdom (Northern Ireland)
Package description:
- Packaging:Cup (Alu/PP), Package_size:In plastic box: 6 cups, Content:10000 doses
- Packaging:Cup (Alu/PP), Package_size:In plastic box: 12 cups, Content:5000 doses
- Packaging:Cup (Alu/PP), Package_size:In plastic box: 12 cups, Content:2500 doses
- Packaging:Cup (Alu/PP), Package_size:In plastic box: 12 cups, Content:1000 doses
- Packaging:Cup (Alu/PP), Package_size:In cardboard box: 10 cups, Content:2500 doses
- Packaging:Cup (Alu/PP), Package_size:In cardboard box: 10 cups, Content:10000 doses
- Packaging:Cup (Alu/PP), Package_size:In cardboard box: 10 cups, Content:5000 doses
- Packaging:Cup (Alu/PP), Package_size:In cardboard box: 10 cups, Content:1000 doses
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet International B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- INTERVET INTERNATIONAL B.V.
Responsible authority:
- European Commission
Authorisation number:
This information is not available for this product.
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Combined File of all Documents
English (PDF)
Download Published on: 16/11/2022
Bulgarian (PDF)
Published on: 18/07/2023
Croatian (PDF)
Published on: 16/11/2022
Czech (PDF)
Published on: 18/07/2023
Danish (PDF)
Published on: 16/11/2022
Dutch (PDF)
Published on: 16/11/2022
Estonian (PDF)
Published on: 16/11/2022
Finnish (PDF)
Published on: 16/11/2022
French (PDF)
Published on: 16/11/2022
German (PDF)
Published on: 16/11/2022
Greek (PDF)
Published on: 16/11/2022
Hungarian (PDF)
Published on: 16/11/2022
Icelandic (PDF)
Published on: 16/11/2022
Italian (PDF)
Published on: 16/11/2022
Latvian (PDF)
Published on: 16/11/2022
Lithuanian (PDF)
Published on: 16/11/2022
Maltese (PDF)
Published on: 16/11/2022
Norwegian (PDF)
Published on: 16/11/2022
Polish (PDF)
Published on: 16/11/2022
Portuguese (PDF)
Published on: 16/11/2022
Romanian (PDF)
Published on: 16/11/2022
Slovak (PDF)
Published on: 16/11/2022
Slovenian (PDF)
Published on: 16/11/2022
Spanish (PDF)
Published on: 16/11/2022
Swedish (PDF)
Published on: 16/11/2022
ema-puar-nobilis-ib-primo-qx-v-2802-par-en.pdf
English (PDF)
Download Published on: 15/03/2023
How useful was this page?:
